Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 1441 to 1455 of 2186 results for guidelines

  1. ColonFlag for identifying people at risk of colorectal cancer (MIB142)

    NICE has developed a medtech innovation briefing (MIB) on ColonFlag for identifying people at risk of colorectal cancer .

    Medtech innovation briefing
    Published
    12 April 2018

  2. Patient self-management plans:- What is the clinical and cost effectiveness of a self-management plan for people with stable angina?

    This research would inform future updates of key recommendations in the guideline. Furthermore the research would be relevant to a...

    Research recommendation
    Published
    9 June 2015

  3. PROPEL sinus implants for maintaining sinus patency after surgery (MIB253)

    NICE has developed a medtech innovation briefing (MIB) on PROPEL sinus implants for maintaining sinus patency after surgery .

    Medtech innovation briefing
    Published
    9 February 2021

  4. Which of the electronic information-sharing systems perform best for the care of people approaching the end of their life?

    end of their life? Any explanatory notes(if applicable) The guideline committee made recommendations on sharing information about people...

    Research recommendation
    Published
    18 November 2019

  5. Predictors of acute physical risk:- What clinical and biochemical markers are the best predictors of acute physical risk for people with eating disorders?

    nutrition). The medical markers of acute risk are used throughout this guideline. Despite their importance, almost all of the...

    Research recommendation
    Published
    12 October 2018

  6. Hearing loss prevalence in people who under-present for hearing loss:- What is the prevalence of hearing loss among populations who under-present for possible hearingloss?

    consider the possibility of hearing loss.The evidence review for the NICE guideline on adult hearing loss highlighted significant health...

    Research recommendation
    Published
    10 December 2018

  7. Advocacy and support for decision-making:- What is the effectiveness, cost effectiveness and acceptability of advocacy as a means of supporting people to make decisions?

    advocacy as a means of supporting people to make decisions. However, the guideline committee thought that this was an area in which...

    Research recommendation
    Published
    18 December 2018

  8. Eladocagene exuparvovec for treating aromatic L-amino acid decarboxylase deficiency (HST26)

    Evidence-based recommendations on eladocagene exuparvovec (Upstaza) for treating aromatic L-amino acid decarboxylase deficiency in people 18 months and over.

    Highly specialised technologies guidance
    Published
    19 April 2023
    View recommendations

    Sections for HST26

  9. Sparsentan for treating primary IgA nephropathy (TA1074)

    Evidence-based recommendations on sparsentan (Filspari) for treating primary immunoglobulin A (IgA) nephropathy in adults.

    Technology appraisal guidance
    Last updated
    9 October 2025
    View recommendations

    Sections for TA1074

  10. Technology appraisal committees

    Membership details, terms of reference, future meeting dates and past meeting minutes for our 4 technology appraisal committees.

  11. Technology appraisal committees

    Membership details, terms of reference, future meeting dates and past meeting minutes for our 4 technology appraisal committees.

  12. Training and support for practitioners:- What is the effectiveness and cost effectiveness of different training programmes on the Mental Capacity Act 2005 at improving practice for practitioners involved in supporting decision-making, conducting capacity assessments and making best interests decisions?

    Any explanatory notes(if applicable) Why this is important:- The guideline committee agreed that effective training and support on the...

    Research recommendation
    Published
    19 December 2018

  13. Ustekinumab for moderately to severely active Crohn's disease after previous treatment (TA456)

    Evidence-based recommendations on ustekinumab (Stelara) for previously treated moderately to severely active Crohn’s disease in adults.

    Technology appraisal guidance
    Published
    12 July 2017
    View recommendations

    Sections for TA456

  14. Maintaining the benefits of early intervention in psychosis services after discharge:- How can the benefits of early intervention in psychosis services be maintained once service users are discharged after 3 years?

    care or community mental health services these gains are diminished. The guideline recommends that trusts consider extending these...

    Research recommendation
    Published
    9 June 2015

  15. Robot-assisted surgery for soft tissue procedures: early value assessment (HTG742)

    Early value assessment (EVA) guidance on robot-assisted surgery for soft tissue procedures.

    HealthTech guidance
    Published
    17 April 2025
    View recommendations

    Sections for HTG742